Overall the findings in the FHM1, FHM2, and MA mouse models support the conclusion that an excessive cortical glutamatergic transmission, due either to increased glutamate release or impaired glutamate clearance (Fig. 1), underlies the facilitation of CSD initiation in these genetic mouse models of migraine. Here, ATP1A2 is linked to migraine disorder.